skip to main content
Visitante
Meu Espaço
Minha Conta
Sair
Identificação
This feature requires javascript
Tags
Revistas Eletrônicas (eJournals)
Livros Eletrônicos (eBooks)
Bases de Dados
Bibliotecas USP
Ajuda
Ajuda
Idioma:
Inglês
Espanhol
Português
This feature required javascript
This feature requires javascript
Primo Search
Busca Geral
Busca Geral
Acervo Físico
Acervo Físico
Produção Intelectual da USP
Produção USP
Search For:
Clear Search Box
Search in:
Busca Geral
Or select another collection:
Search in:
Busca Geral
Busca Avançada
Busca por Índices
This feature requires javascript
This feature requires javascript
Triple negative tumours: a critical review
Reis-Filho, J S ; Tutt, A N J
Histopathology, 2008-01, Vol.52 (1), p.108-118
[Periódico revisado por pares]
Oxford, UK: Blackwell Publishing Ltd
Texto completo disponível
Citações
Citado por
Exibir Online
Detalhes
Resenhas & Tags
Mais Opções
Nº de Citações
This feature requires javascript
Enviar para
Adicionar ao Meu Espaço
Remover do Meu Espaço
E-mail (máximo 30 registros por vez)
Imprimir
Link permanente
Referência
EasyBib
EndNote
RefWorks
del.icio.us
Exportar RIS
Exportar BibTeX
This feature requires javascript
Título:
Triple negative tumours: a critical review
Autor:
Reis-Filho, J S
;
Tutt, A N J
Assuntos:
adjuvant therapy
;
Algorithms
;
basal-like
;
Biological and medical sciences
;
BRCA1
;
breast cancer
;
Breast Neoplasms - genetics
;
Breast Neoplasms - metabolism
;
Female
;
Gene Expression Profiling
;
Genes, BRCA1
;
Gynecology. Andrology. Obstetrics
;
Humans
;
Investigative techniques, diagnostic techniques (general aspects)
;
Mammary gland diseases
;
Medical sciences
;
Neoplasms, Basal Cell - genetics
;
Neoplasms, Basal Cell - metabolism
;
Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques
;
Receptor, ErbB-2 - genetics
;
Receptor, ErbB-2 - metabolism
;
Receptors, Estrogen - genetics
;
Receptors, Estrogen - metabolism
;
Receptors, Progesterone - genetics
;
Receptors, Progesterone - metabolism
;
triple negative
;
Tumors
É parte de:
Histopathology, 2008-01, Vol.52 (1), p.108-118
Notas:
istex:D7130A32435CC6C532FDDCBA2D7BF6B405EB6A23
ArticleID:HIS2889
ark:/67375/WNG-XXTW470L-T
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
ObjectType-Review-1
Descrição:
Breast cancer is a heterogeneous disease that encompasses several distinct entities with remarkably different biological characteristics and clinical behaviour. Currently, breast cancer patients are managed according to algorithms based on a constellation of clinical and histopathological parameters in conjunction with assessment of hormone receptor (oestrogen and progesterone receptor) status and HER2 overexpression/gene amplification. Although effective tailored therapies have been developed for patients with hormone receptor‐positive or HER2+ disease, chemotherapy is the only modality of systemic therapy for patients with breast cancers lacking the expression of these markers (triple‐negative cancers). Recent microarray expression profiling analyses have demonstrated that breast cancers can be systematically characterized into biologically and clinically meaningful groups. These studies have led to the re‐discovery of basal‐like breast cancers, which preferentially show a triple‐negative phenotype. Both triple‐negative and basal‐like cancers preferentially affect young and African‐American women, are of high histological grade and have more aggressive clinical behaviour. Furthermore, a significant overlap between the biological and clinical characteristics of sporadic triple‐negative and basal‐like cancers and breast carcinomas arising in BRCA1 mutation carriers has been repeatedly demonstrated. In this review, we critically address the characteristics of basal‐like and triple‐negative cancers, their similarities and differences, their response to chemotherapy as well as strategies for the development of novel therapeutic targets for these aggressive types of breast cancer. In addition, the possible mechanisms are discussed leading to BRCA1 pathway dysfunction in sporadic triple‐negative and basal‐like cancers and animal models for these tumour types.
Editor:
Oxford, UK: Blackwell Publishing Ltd
Idioma:
Inglês
Links
View record in Pascal Francis
View this record in MEDLINE/PubMed
This feature requires javascript
This feature requires javascript
Voltar para lista de resultados
This feature requires javascript
This feature requires javascript
Buscando em bases de dados remotas. Favor aguardar.
Buscando por
em
scope:(USP_PRODUCAO),scope:(USP_EBOOKS),scope:("PRIMO"),scope:(USP),scope:(USP_EREVISTAS),scope:(USP_FISICO),primo_central_multiple_fe
Mostrar o que foi encontrado até o momento
This feature requires javascript
This feature requires javascript